NC
EXAS

NBW Capital’s Exact Sciences EXAS Stock Holding History

NBW Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.53M Buy
+66,353
New +$3.37M 0.76% 57

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

NBW Capital's EXAS Position: Q2 2025 in Review

NBW Capital opened a new position in Exact Sciences (EXAS) in Q2 2025: 66,353 shares worth $3.53M. The stake represents 0.76% of the portfolio and ranks #57 among its holdings.

557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • NBW Capital held 66,353 shares of Exact Sciences worth $3.53M as of Q2 2025.
  • Exact Sciences was a new NBW Capital position in Q2 2025.
  • Exact Sciences made up 0.76% of NBW Capital's portfolio in Q2 2025, its #57 holding.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.